Factors That May Affect Your Starting Dose Starting dose and escalation speed are influenced by BMI, renal and hepatic function, gastrointestinal history, concomitant glucose-lowering medications, and age
Gallstones and ileus were less likely for patients prescribed most of the GLP-1 medications studied compared to diabetic patients not prescribed a GLP-1 medication
In a network meta-analysis, the odds of dementia among individuals treated with dulaglutide, exenatide, or liraglutide was reduced by 66% relative to non-GLP1AR users [42]
The FDA explains that external use means avoiding the lips and any parts of the body covered by a mucous membrane, such as the eyes and inside of the nose
If Ozempic were inadvertently injected directly into a vein, the entire dose would enter the systemic circulation immediately rather than being absorbed gradually from subcutaneous tissue